Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcomes of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Peripheral Artery Disease and Type 2 Diabetes.

Journal of the American Heart Association·2026
Same author

AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art review.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

REN: Anatomically-Informed Mixture-of-Experts for Interstitial Lung Disease Diagnosis.

IEEE transactions on medical imaging·2026
Same author

Efficacy of torsemide versus furosemide in heart failure: a systematic review and meta-analysis of randomized controlled trials.

Archives of medical sciences. Atherosclerotic diseases·2026
Same author

Outcomes of TAVR Plus TEVAR Versus TAVR Alone in Patients with Concomitant Aortic Stenosis and Thoracic Aortic Aneurysm.

Heart, lung & circulation·2026
Same author

Transcatheter Tricuspid Valve Intervention Versus Optimal Medical Therapy in Symptomatic Tricuspid Regurgitation: A Systematic Review and Meta-Analysis of Randomized and Observational Studies.

The American journal of cardiology·2026

Related Experiment Video

Updated: Jun 25, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

Diagnostic Approach to Left Ventricular Hypertrophy: A Review.

Sukriti Banthiya1, Ankit Agrawal2, Devesh Rai3

  • 1Department of Cardiovascular Disease, Henry Ford Providence Southfield, MI.

US Cardiology
|June 24, 2026
PubMed
Summary
This summary is machine-generated.

Left ventricular hypertrophy (LVH) affects 10-20% of adults and is a risk factor for heart events. This review covers LVH causes, diagnosis, and imaging techniques.

Keywords:
Hypertrophic cardiomyopathyaortic stenosisathlete’s heartcardiac amyloidosiscardiac sarcoidosisinfiltrative cardiomyopathyleft ventricular hypertrophy

More Related Videos

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

Related Experiment Videos

Last Updated: Jun 25, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Left ventricular hypertrophy (LVH) is a common cardiac finding in 10-20% of adults.
  • LVH can stem from physiological stress, primary pathologies like cardiac amyloidosis or sarcoidosis, or genetic conditions such as hypertrophic cardiomyopathy.
  • LVH independently predicts adverse cardiovascular events, irrespective of its underlying cause.

Purpose of the Study:

  • To review the diverse etiologies of left ventricular hypertrophy.
  • To outline the clinical approach for diagnosing and managing LVH.
  • To discuss the role of multimodality imaging in evaluating patients with LVH.

Main Methods:

  • Literature review of studies on left ventricular hypertrophy.
  • Synthesis of information on etiological factors.
  • Analysis of clinical diagnostic strategies.
  • Evaluation of multimodality imaging techniques.

Main Results:

  • LVH has multiple causes, including physiological adaptation and various pathological conditions.
  • A systematic clinical approach is crucial for identifying the etiology of LVH.
  • Multimodality imaging plays a key role in the comprehensive assessment of LVH.

Conclusions:

  • Understanding the etiology of LVH is critical for patient management.
  • Integrated clinical and imaging approaches improve diagnostic accuracy for LVH.
  • Early identification and management of LVH can mitigate cardiovascular event risk.